Stereotaxis (STXS) Other Non-Current Assets (2010 - 2026)
Stereotaxis' (STXS) quarterly Other Non-Current Assets came in at $330000.0 in Q1 2026, up 230.0% year-on-year from $100000.0 in Q1 2025, and up 18.71% on a QoQ basis from $278000.0 in Q4 2025.
Stereotaxis (STXS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Other Non-Current Assets data on file, last reported at $330000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 230.0% year-over-year to $330000.0 in Q1 2026; TTM through Mar 2026 was $330000.0, a 230.0% increase from a year earlier, with the FY2025 full-year figure at $278000.0, up 159.81% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $330000.0, up from $278000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for STXS reached as high as $1.3 million in Q4 2022 and fell as low as $100000.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $494705.9 across 5 years, with a median of $350000.0 in 2023.
- Across the five-year window, Other Non-Current Assets surged 1123.66% in 2022 and plunged 83.33% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then sank by 83.15% to $219000.0 in 2023, then plunged by 51.14% to $107000.0 in 2024, then soared by 159.81% to $278000.0 in 2025, then rose by 18.71% to $330000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $330000.0 in Q1 2026, $278000.0 in Q4 2025, and $280000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 107,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 481,000.00 |
| Mar 31, 2023 | 612,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 875,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 952,000.00 |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 383,000.00 |